Inventor · disambiguated record
John C. Mckew
Also filed as: MCKEW JOHN · MCKEW JOHN C
22 granted patents·5 pending applications·611 citations·filing 2000–2025
96Inventor score
Top patents by PatentIndex Score
27 records- 0197US6828344B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 7, 2004·109 cites·16 claims
- 0297US6630496B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Oct 7, 2003·145 cites·18 claims
- 0397US6500853B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 31, 2002·104 cites·19 claims
- 0495US6797708B2Inhibitors of cytosolic phospholipase A2WYETH CORP·Filed 2002·Granted Sep 28, 2004·66 cites·47 claims
- 0594US6916841B2Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2002·Granted Jul 12, 2005·45 cites·28 claims
- 0691US6984735B2Process for making an aldehydeWYETH CORP·Filed 2003·Granted Jan 10, 2006·33 cites·14 claims
- 0789US11969416B1Compactable oral formulations of ibutamorenLUMOS PHARMA INC·Filed 2022·Granted Apr 30, 2024·1 cites·24 claims
- 0889US6635771B2N-benzhydryl indole compoundsWYETH CORP·Filed 2002·Granted Oct 21, 2003·29 cites·8 claims
- 0988US7632838B211-beta HSD1 inhibitorsWYETH CORP·Filed 2007·Granted Dec 15, 2009·17 cites·69 claims
- 1087US9682983B2BMP inhibitors and methods of use thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Jun 20, 2017·10 cites·19 claims
- 1187US7557135B2Inhibitors of cytosolic phospholipase A2WYETH CORP·Filed 2006·Granted Jul 7, 2009·12 cites·2 claims
- 1286US7605156B2Methods for the use of inhibitors of cytosolic phospholipase A2WYETH CORP·Filed 2005·Granted Oct 20, 2009·10 cites·34 claims
- 1382US7101875B2Methods for treating arthritic disordersWYETH CORP·Filed 2002·Granted Sep 5, 2006·13 cites·48 claims
- 1481US10017516B2BMP inhibitors and methods of use thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Jul 10, 2018·3 cites·5 claims
- 1578US11020422B2Cyclodextrin for the treatment of lysosomal storage diseasesUS HEALTH·Filed 2017·Granted Jun 1, 2021·1 cites·6 claims
- 1678US9663485B2Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage DisordersUS HEALTH·Filed 2013·Granted May 30, 2017·3 cites·17 claims
- 1777US10513521B2Compositions and methods for inhibiting BMPBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Dec 24, 2019·3 cites·19 claims
- 1875US7906548B2Methods for the use of inhibitors of cytosolic phospholipase A2WYETH LLC·Filed 2009·Granted Mar 15, 2011·2 cites·22 claims
- 1973US12390452B2Compactable oral formulations of ibutamorenLUMOS PHARMA INC·Filed 2024·Granted Aug 19, 2025·0 cites·27 claims
- 2070US7713964B2Methods for treating asthmatic conditionsWYETH LLC·Filed 2002·Granted May 11, 2010·5 cites·48 claims
- 2157US2010029648A111-Beta HSD1 InhibitorsXIANG JASON SHAOYUN·Filed 2009·Application pending·0 cites
- 2255US8283373B2Inhibitors of cytosolic phospholipase A2MCKEW JOHN C·Filed 2009·Granted Oct 9, 2012·0 cites·15 claims
- 2354US10370348B2Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disordersUS HEALTH·Filed 2017·Granted Aug 6, 2019·0 cites·1 claims
- 2453US2025332149A1Piperidine compounds and pharmaceutical compositionsLUMOS PHARMA INC·Filed 2025·Application pending·0 cites
- 2549US2015031693A1Pak inhibitors for the treatment of fragile x syndromeAFRAXIS HOLDINGS INC·Filed 2012·Application pending·0 cites
- 2647US2015216895A1Cyclodextrin for the treatment of lysosomal storage diseasesUS HEALTH·Filed 2013·Application pending·0 cites
- 2736US2006025445A111-Beta HSD1 inhibitorsXIANG JASON S·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →